Clinical Trial Update: Gut Microbiome in DLBCL Treated With Glofitamab

View source ↗

Summary

Clinical trial update examining the gut microbiome in patients with diffuse large B-cell lymphoma treated with glofitamab; the study status is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Glofitamab (glofitamab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: DLBCL, Glofitamab | Status: NOT_YET_RECRUITING